Finance
Finance
ื“ืฃ ื”ื‘ื™ืชINCY โ€ข NASDAQ
Incyte Corp
โ€77.65ย โ€$
ืื—ืจื™ ืฉืขื•ืช ื”ืžืกื—ืจ:
โ€78.43ย โ€$
(1.00%)+0.78
ืกื’ื•ืจ: 6 ื‘ืื•ื’ืณ, 17:18:44 GMT-4โ€Ž · USD · NASDAQ · ื›ืชื‘ ื•ื™ืชื•ืจ
ืžื ื™ื”ื ื™ื™ืจ ืขืจืš ืฉืจืฉื•ื ื‘ืืจื”"ื‘ื”ืžืฉืจื“ ื”ืจืืฉื™ ืฉืœ ื”ื—ื‘ืจื” ื ืžืฆื ื‘ืืจื”"ื‘
ืฉืขืจ ืกื’ื™ืจื” ืงื•ื“ื
โ€77.72ย โ€$
ื˜ื•ื•ื— ื™ื•ืžื™
โ€76.45ย โ€$ - โ€79.43ย โ€$
ื˜ื•ื•ื— ืฉื ืชื™
โ€53.56ย โ€$ - โ€83.94ย โ€$
ืฉื•ื•ื™ ืฉื•ืง
15.16Bโ€ USD
ื ืคื— ืžืกื—ืจ ืžืžื•ืฆืข
1.76Mโ€
ืžื›ืคื™ืœ ืจื•ื•ื—
17.84
ืชืฉื•ืืช ื“ื™ื‘ื™ื“ื ื“
-
ื‘ื•ืจืกื” ืขื™ืงืจื™ืช
NASDAQ
ื›ืกืคื™ื
ื”ืฆื”ืจืช ื”ื›ื ืกื”
ื”ื›ื ืกื”
ืจื•ื•ื— ื ืงื™
(USD)ื™ื•ื ื™ 2025ืฉื™ื ื•ื™ ืžืฉื ื” ืœืฉื ื”
ื”ื›ื ืกื”
1.22Bโ€16.46%
ื”ื•ืฆืื•ืช ืชืคืขื•ืœื™ื•ืช
367.96Mโ€15.09%
ืจื•ื•ื— ื ืงื™
405.00Mโ€191.09%
ืฉื•ืœื™ ืจื•ื•ื— ื ืงื™
33.32178.22%
ืจื•ื•ื—ื™ื ืœืžื ื™ื”
1.57186.26%
ืจื•ื•ื— ืœืคื ื™ ืจื™ื‘ื™ืช, ืžื™ืกื™ื, ืคื—ืช ื•ื”ืคื—ืชื•ืช
334.51Mโ€179.06%
ืฉื™ืขื•ืจ ืžืก ืืคืงื˜ื™ื‘ื™
27.42%โ€”
ืกืš ื›ืœ ื”ื ื›ืกื™ื
ื—ื‘ื•ืช ื›ื•ืœืœืช
(USD)ื™ื•ื ื™ 2025ืฉื™ื ื•ื™ ืžืฉื ื” ืœืฉื ื”
ืžื–ื•ืžื ื™ื ื•ื”ืฉืงืขื•ืช ืœื˜ื•ื•ื— ืงืฆืจ
2.42Bโ€59.39%
ืกืš ื›ืœ ื”ื ื›ืกื™ื
5.82Bโ€24.87%
ื—ื‘ื•ืช ื›ื•ืœืœืช
1.65Bโ€โ€Ž-0.86%
ื”ื•ืŸ ืขืฆืžื™ ื›ื•ืœืœ
4.17Bโ€โ€”
ื”ื•ืŸ ืขื•ืžื“
195.28Mโ€โ€”
ืžื›ืคื™ืœ ื”ื•ืŸ
3.62โ€”
ืชืฉื•ืื” ืขืœ ื”ื ื›ืกื™ื
13.46%โ€”
ืชืฉื•ืื” ืขืœ ื”ื•ืŸ
19.66%โ€”
ืฉื™ื ื•ื™ ื‘ืฉื•ื•ื™ ืžื–ื•ืžื ื™ื
(USD)ื™ื•ื ื™ 2025ืฉื™ื ื•ื™ ืžืฉื ื” ืœืฉื ื”
ืจื•ื•ื— ื ืงื™
405.00Mโ€191.09%
ืžื–ื•ืžื ื™ื ืžืคืขื™ืœื•ืช ืฉื•ื˜ืคืช
44.74Mโ€107.77%
ืžื–ื•ืžืŸ ืžื”ืฉืงืขื•ืช
โ€Ž-18.87Mโ€โ€Ž-108.83%
ืžื–ื•ืžืŸ ืžืžื™ืžื•ืŸ
โ€Ž-11.25Mโ€99.44%
ืฉื™ื ื•ื™ ื‘ืฉื•ื•ื™ ืžื–ื•ืžื ื™ื
13.43Mโ€100.57%
ืชื–ืจื™ื ืžื–ื•ืžื ื™ื ืคื ื•ื™
โ€Ž-302.22Mโ€17.10%
ืžื™ื“ืข ื›ืœืœื™
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
ืžื ื›"ืœ
ืชืืจื™ืš ื”ืงืžื”
2002
ืžืฉืจื“ื™ื ืจืืฉื™ื™ื
ื•ื™ืœืžื™ื ื’ื˜ื•ืŸ, ื“ืœืื•ื•ืจ
ืืจืฆื•ืช ื”ื‘ืจื™ืช
ืืชืจ
incyte.com
ืขื•ื‘ื“ื™ื
2,617
ืžื ื™ื•ืช ื ื•ืกืคื•ืช
ืžื ื™ื•ืช ืฉืขืฉื•ื™ื•ืช ืœืขื ื™ื™ืŸ ืื•ืชืš
ื”ืจืฉื™ืžื” ื”ื–ื• ื ื•ืฆืจืช ืžื—ื™ืคื•ืฉื™ื ืื—ืจื•ื ื™ื, ืžื ื™ื™ืจื•ืช ืขืจืš ื‘ืžืขืงื‘ ื•ืžืคืขื™ืœื•ื™ื•ืช ืื—ืจื•ืช. ืžื™ื“ืข ื ื•ืกืฃ

ื›ืœ ื”ื ืชื•ื ื™ื ื•ื”ืžื™ื“ืข ืžืกื•ืคืงื™ื ื‘ืฆื•ืจืชื ื”ืžืงื•ืจื™ืช ืœืžื˜ืจื•ืช ืื™ื ืคื•ืจืžื˜ื™ื‘ื™ื•ืช ืื™ืฉื™ื•ืช ื‘ืœื‘ื“, ื•ืœื ื ื•ืขื“ื• ืœืกืคืง ื™ื™ืขื•ืฅ ื›ืœื›ืœื™ ืื• ืœืžื˜ืจื•ืช ืžืกื—ืจ, ื”ืฉืงืขื”, ืžื™ืกื•ื™, ืžืฉืคื˜, ื—ืฉื‘ื•ื ืื•ืช ืื• ื›ืœ ื™ื™ืขื•ืฅ ืื—ืจ. Google ืื™ื ื” ืžืฆื™ืขื” ื™ื™ืขื•ืฅ ื”ืฉืงืขื•ืช ืื• ื™ื™ืขื•ืฅ ืคื™ื ื ืกื™ ื•ืื™ื ื” ืžื‘ื™ืขื” ืขืžื“ื”, ื”ืžืœืฆื” ืื• ื“ืขื” ื›ืœืฉื”ื™ ื‘ื›ืœ ื”ืงืฉื•ืจ ืœื›ืœ ืื—ืช ืžื”ื—ื‘ืจื•ืช ื”ื›ืœื•ืœื•ืช ื‘ืจืฉื™ืžื” ื–ื•, ืื• ืœื ื™ื™ืจื•ืช ื”ืขืจืš ืฉืžื•ื ืคืงื™ื ืขืœ ื™ื“ื™ ื—ื‘ืจื•ืช ืืœื”. ื™ืฉ ืœื”ืชื™ื™ืขืฅ ืขื ืกื•ื›ืŸ ื”ืžื ื™ื•ืช ืื• ื”ื™ื•ืขืฅ ื”ืคื™ื ื ืกื™ ืฉืœืš ื›ื“ื™ ืœืืžืช ืืช ื”ืชืžื—ื•ืจ ืœืคื ื™ ื‘ื™ืฆื•ืข ืขืกืงืช ืกื—ืจ. ืžื™ื“ืข ื ื•ืกืฃ
ืื ืฉื™ื ื—ื™ืคืฉื• ื’ื
ื—ื™ืคื•ืฉ
ื ื™ืงื•ื™ ื”ื—ื™ืคื•ืฉ
ืกื’ื™ืจืช ื”ื—ื™ืคื•ืฉ
ืืคืœื™ืงืฆื™ื•ืช Google
ื”ืชืคืจื™ื˜ ื”ืจืืฉื™